Literature DB >> 22471278

Murine lupus strains differentially model unique facets of human lupus serology.

L Li1, S Nukala, Y Du, J Han, K Liu, J Hutcheson, S Pathak, Q Li, C Mohan.   

Abstract

Systemic lupus erythematosus (SLE) is a polygenic autoimmune disease characterized by the production of anti-nuclear autoantibodies that lead to subsequent end organ damage. Previous array-based studies in patients with SLE have shown that high immunoglobulin (Ig)G anti-nuclear autoantibody reactivity was associated with severe renal lupus, whereas IgM polyreactivity was associated with less severe disease. To ascertain how different murine lupus strains recapitulate these different autoantibody profiles seen in patients, serum from New Zealand black (NZB)/NZ white (W) F(1), Murphy Roths large (MRL)/lpr, NZ mixed (M)2410 and BXSB strains were compared using a comprehensive array-based screen. The array results were verified using enzyme-linked immunosorbent assays (ELISAs). Serum from MRL/lpr mice exhibited high levels of IgG anti-nuclear antibodies as well as anti-glomerular antibodies and variable levels of antibodies to myosin, Matrigel and thyroglobulin. Elevated anti-nuclear IgG antibodies were associated with severe nephritis in this strain. In contrast, NZM2410 mice exhibited lower IgG autoantibody levels with less severe nephritis but a significantly higher polyreactive IgM autoantibody profile. ELISA analysis confirmed these results. The NZB/NZW F(1) and BXSB strains exhibited an intermediate serological profile. Hence, just as in patients with SLE, whereas strong IgG reactivity to nuclear antigens is associated with severe renal disease, a polyreactive IgM seroprofile is also less ominous in murine lupus.
© 2012 The Authors;Clinical and Experimental Immunology © 2012 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22471278      PMCID: PMC3390518          DOI: 10.1111/j.1365-2249.2012.04568.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin.

Authors:  R W Burlingame; R L Rubin
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

2.  Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.

Authors:  Chuancang Jiang; Ming-Lang Zhao; Richard M Scearce; Marilyn Diaz
Journal:  Arthritis Rheum       Date:  2011-04

Review 3.  Murine models of systemic lupus erythematosus.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

4.  Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis.

Authors:  X J Zhou; Z Laszik; X Q Wang; F G Silva; N D Vaziri
Journal:  Lab Invest       Date:  2000-12       Impact factor: 5.662

5.  Autoantibodies in systemic lupus erythematosus and normal subjects.

Authors:  E Pateraki; E Kaklamani; P Kaklamanis; R Portocalas; A Aessopos
Journal:  Clin Rheumatol       Date:  1986-09       Impact factor: 2.980

6.  Strain distribution pattern of susceptibility to immune-mediated nephritis.

Authors:  Chun Xie; Ruchi Sharma; Hongwei Wang; Xin J Zhou; Chandra Mohan
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

7.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus.

Authors:  Melissa R Arbuckle; Micah T McClain; Mark V Rubertone; R Hal Scofield; Gregory J Dennis; Judith A James; John B Harley
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

8.  The influence of the lpr gene on B cell activation: differential antibody expression in lpr congenic mouse strains.

Authors:  R W Warren; S A Caster; J B Roths; E D Murphy; D S Pisetsky
Journal:  Clin Immunol Immunopathol       Date:  1984-04

9.  Mechanisms of autoantibody production in autoimmune MRL mice.

Authors:  D S Pisetsky; G A McCarty; D V Peters
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

10.  Pathogenic profiles and molecular signatures of antinuclear autoantibodies rescued from NZM2410 lupus mice.

Authors:  Zhiyan Liang; Chun Xie; Cui Chen; Desi Kreska; Kelvin Hsu; Liunan Li; Xin J Zhou; Chandra Mohan
Journal:  J Exp Med       Date:  2004-02-02       Impact factor: 14.307

View more
  11 in total

1.  Suppression of systemic autoimmunity by the innate immune adaptor STING.

Authors:  Shruti Sharma; Allison M Campbell; Jennie Chan; Stefan A Schattgen; Gregory M Orlowski; Ribhu Nayar; Annie H Huyler; Kerstin Nündel; Chandra Mohan; Leslie J Berg; Mark J Shlomchik; Ann Marshak-Rothstein; Katherine A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

2.  Abrogated AID Function Prolongs Survival and Diminishes Renal Pathology in the BXSB Mouse Model of Systemic Lupus Erythematosus.

Authors:  Jing Zhu; Alayna N Hay; Ashley A Potter; Madison W Richwine; Thomas Sproule; Tanya LeRoith; John Wilson; Muneer G Hasham; Derry C Roopenian; Caroline M Leeth
Journal:  J Immunol       Date:  2020-01-27       Impact factor: 5.422

3.  Circadian clock cryptochrome proteins regulate autoimmunity.

Authors:  Qi Cao; Xuan Zhao; Jingwen Bai; Sigal Gery; Haibo Sun; De-Chen Lin; Qi Chen; Zhengshan Chen; Lauren Mack; Henry Yang; Ruishu Deng; Xianping Shi; Ling-Wa Chong; Han Cho; Jianjun Xie; Quan-Zhen Li; Markus Müschen; Annette R Atkins; Christopher Liddle; Ruth T Yu; Serhan Alkan; Jonathan W Said; Ye Zheng; Michael Downes; Ronald M Evans; H Phillip Koeffler
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-06       Impact factor: 11.205

4.  Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis.

Authors:  Yumin Xia; Leal C Herlitz; Simona Gindea; Jing Wen; Rahul D Pawar; Alexander Misharin; Harris Perlman; Lan Wu; Ping Wu; Jennifer S Michaelson; Linda C Burkly; Chaim Putterman
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

5.  The role of microparticles in the generation of immune complexes in murine lupus.

Authors:  Anirudh J Ullal; David S Pisetsky
Journal:  Clin Immunol       Date:  2012-10-13       Impact factor: 3.969

6.  Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr Mice.

Authors:  Fleur Schaper; Mirjan M van Timmeren; Arjen Petersen; Gerda Horst; Marc Bijl; Pieter C Limburg; Johanna Westra; Peter Heeringa
Journal:  Mol Med       Date:  2016-01-13       Impact factor: 6.354

7.  Ranking the impact of human health disorders on gut metabolism: systemic lupus erythematosus and obesity as study cases.

Authors:  David Rojo; Arancha Hevia; Rafael Bargiela; Patricia López; Adriana Cuervo; Sonia González; Ana Suárez; Borja Sánchez; Mónica Martínez-Martínez; Christian Milani; Marco Ventura; Coral Barbas; Andrés Moya; Antonio Suárez; Abelardo Margolles; Manuel Ferrer
Journal:  Sci Rep       Date:  2015-02-06       Impact factor: 4.379

Review 8.  Sex-specific effects of LiCl treatment on preservation of renal function and extended life-span in murine models of SLE: perspective on insights into the potential basis for survivorship in NZB/W female mice.

Authors:  David A Hart
Journal:  Biol Sex Differ       Date:  2016-06-27       Impact factor: 5.027

Review 9.  Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis.

Authors:  Susan Yung; Desmond Yh Yap; Tak Mao Chan
Journal:  F1000Res       Date:  2017-06-13

10.  Bradykinin 1 receptor blockade subdues systemic autoimmunity, renal inflammation, and blood pressure in murine lupus nephritis.

Authors:  Ling Qin; Yong Du; Huihua Ding; Anam Haque; John Hicks; Claudia Pedroza; Chandra Mohan
Journal:  Arthritis Res Ther       Date:  2019-01-08       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.